IP Library Assignment 050150/0044
Patent Assignment
Reel/Frame 050150/0044

Change of Name

Recorded: 2019-03-20 Pages: 6
Assignor
VITAE PHARMACEUTICALS, INC.
Executed: 2018-12-31
Assignee
VITAE PHARMACEUTICALS, LLC
5 GIRALDA FARMS, MADISON, NEW JERSEY, 07940
Covered Properties (25)
Liver X Receptor Modulators
Patent: 9,073,931 →
Application: 14/385,671 →
Publication: US 2015/0065515
Liver X Receptor Modulators
Patent: 9,006,244 →
Application: 14/385,688 →
Publication: US 2015/0051214
Liver X Receptor Modulators
Patent: 9,006,245 →
Application: 14/547,804 →
Publication: US 2015/0080406
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Patent: 9,266,886 →
Application: 14/609,798 →
Publication: US 2015/0218160
Liver X Receptor Modulators
Patent: 9,388,190 →
Application: 14/657,179 →
Publication: US 2015/0246924
Liver X Receptor Modulators
Patent: 9,416,135 →
Application: 14/721,262 →
Publication: US 2015/0336963
Thiazolopyrrolidine Inhibitors of Ror-Gamma
Patent: 9,868,748 →
Application: 14/888,129 →
Publication: US 2017/0008910
Isoindoline Inhibitors of Ror-Gamma
Patent: 9,845,308 →
Application: 14/933,468 →
Publication: US 2016/0122318
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Patent: 9,663,515 →
Application: 14/933,524 →
Publication: US 2016/0122345
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Patent: 9,624,217 →
Application: 14/990,430 →
Publication: US 2016/0200724
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Patent: 9,481,674 →
Application: 15/178,796 →
Liver X Receptor Modulators
Patent: 9,814,715 →
Application: 15/182,749 →
Publication: US 2017/0136017
Liver X Receptor Modulators
Patent: 9,707,232 →
Application: 15/204,422 →
Publication: US 2017/0007603
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Patent: 9,796,710 →
Application: 15/277,836 →
Publication: US 2017/0081327
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Application: 15/455,481 →
Publication: US 2017/0260180
Piperazine Derivatives as Liver X Receptor Modulators
Application: 15/502,356 →
Publication: US 2017/0226067
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Application: 15/709,903 →
Publication: US 2018/0222902
Substituted Indoles as Modulators of Ror-Gamma
Application: 15/749,322 →
Publication: US 2018/0222860
Modulators of Ror-Gamma
Application: 15/776,836 →
Publication: US 2019/0322687
Compounds for Use in Treating Acute Coronary Syndrome and Related Conditions
Application: 15/869,300 →
Publication: US 2018/0133220
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Application: 16/025,155 →
Publication: US 2018/0370968
Benzimidazole Derivatives as Modulators of Ror-Gamma
Application: 16/073,503 →
Publication: US 2019/0352286
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Application: 16/110,224 →
Dihydropyrrolopyridine Inhibitors of Ror-Gamma
Application: 16/115,860 →
Liver X Receptor Modulators
Application: 16/145,749 →
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 17, 2014
From: DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA; LOTESTA, STEPHEN D.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 033757/0813 →
Assignment of Assignor's Interest Sep 17, 2014
From: DONG, CHENGGUO; FAN, YI; LOTESTA, STEPHEN D.; SINGH, SURESH B.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 033757/0623 →
Assignment of Assignor's Interest Nov 19, 2014
From: LEFTHERIS, KATERINA; ZHUANG, LINGHANG
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 034211/0724 →
Assignment of Assignor's Interest Apr 6, 2015
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 035338/0013 →
Assignment of Assignor's Interest May 12, 2015
From: DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA; LOTESTA, STEPHEN D.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 035615/0023 →
Assignment of Assignor's Interest May 27, 2015
From: DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA; LOTESTA, STEPHEN D.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 035718/0757 →
Assignment of Assignor's Interest Nov 24, 2015
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 037155/0563 →
Assignment of Assignor's Interest Dec 8, 2015
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 037232/0863 →
Assignment of Assignor's Interest Feb 29, 2016
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 037958/0349 →
Assignment of Assignor's Interest Mar 30, 2016
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 038304/0266 →
Assignment of Assignor's Interest Jun 27, 2016
From: CLAREMON, DAVID A.; YUAN, JING; ZHAO, WEI; ZHENG, YAJUN
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 039173/0350 →
Assignment of Assignor's Interest Sep 15, 2016
From: DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA; LOTESTA, STEPHEN D.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 039756/0821 →
Assignment of Assignor's Interest Sep 22, 2016
From: DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA; LOTESTA, STEPHEN D.
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 039834/0915 →
Assignment of Assignor's Interest Apr 4, 2017
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 041846/0131 →
Assignment of Assignor's Interest Apr 7, 2017
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 041927/0468 →
Assignment of Assignor's Interest Apr 7, 2017
From: CLAREMON, DAVID A.; DONG, CHENGGUO; FAN, YI; LEFTHERIS, KATERINA
To: VITAE PHARMACEUTICALS, INC. (121374)
Reel/Frame 041927/0156 →
Assignment of Assignor's Interest Oct 16, 2017
From: CLAREMON, DAVID A.; DILLARD, LAWRENCE WAYNE; DONG, CHENGGUO; FAN, YI
To: VITAE PHARMACEUTICALS, INC.
Reel/Frame 043871/0903 →